Thursday, October 3, 2013
Cynvenio Debuts New Cancer Diagnostics Product
Westlake Village-based Cynvenio, a developer of molecular analysis technology being used for cancer treatment and management, has launched a new product for cancer diagnostics. The company said it has launched the ClearID Breast Cancer monitoring program, a cancer diagnostics testing program which uses molecular analysis of tumor biomarkers in blood, to help in early detection of breast cancer recurrence. Cynvenio said its blood-based, genomic testing product uses a standard blood sample, and detects the presence of or absence of cancer cells circulating in the blood.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More